Figure 2
From: The TLR7 agonist Imiquimod promote the immunogenicity of msenchymal stem cells
Imiquimod enhanced the expression of co-stimulatory factors and inhibted the stem cell surface markers. A: co-stimulatory molecules, B: surface markers.
Figure 2 | Biological Research